OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology
Zhulin Wu, Chunshan Wei, Lianan Wang, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 11
Zhulin Wu, Chunshan Wei, Lianan Wang, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 11
Showing 11 citing articles:
Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases
Xiaolin Xiao, Qichao Hu, Xinyu Deng, et al.
Pharmacological Research (2021) Vol. 175, pp. 106005-106005
Closed Access | Times Cited: 49
Xiaolin Xiao, Qichao Hu, Xinyu Deng, et al.
Pharmacological Research (2021) Vol. 175, pp. 106005-106005
Closed Access | Times Cited: 49
The combination of Schisandrin C and Luteolin synergistically attenuates hepatitis B virus infection via repressing HBV replication and promoting cGAS-STING pathway activation in macrophages
Zhixin Wu, Xiaomei Zhao, Ruisheng Li, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Zhixin Wu, Xiaomei Zhao, Ruisheng Li, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Information Extraction from the Text Data on Traditional Chinese Medicine: A Review on Tasks, Challenges, and Methods from 2010 to 2021
Tingting Zhang, Zonghai Huang, Yaqiang Wang, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 15
Tingting Zhang, Zonghai Huang, Yaqiang Wang, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 15
Advances in the Mechanism of Luteolin against Hepatocellular Carcinoma Based on Bioinformatics and Network Pharmacology
Yunqi Han, Yunfeng Xiao, Lei Yu, et al.
Journal of Cancer (2023) Vol. 14, Iss. 6, pp. 966-980
Open Access | Times Cited: 8
Yunqi Han, Yunfeng Xiao, Lei Yu, et al.
Journal of Cancer (2023) Vol. 14, Iss. 6, pp. 966-980
Open Access | Times Cited: 8
LncRNA LINC00924 upregulates NDRG2 to inhibit epithelial‐mesenchymal transition via sponging miR‐6755‐5p in hepatitis B virus‐related hepatocellular carcinoma
Kai Yu, Yunhua Mei, Zhongyi Wang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2702-2713
Closed Access | Times Cited: 12
Kai Yu, Yunhua Mei, Zhongyi Wang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2702-2713
Closed Access | Times Cited: 12
Research progress on pharmacological effects against liver and eye diseases of flavonoids present in Chrysanthum indicum L., Chrysanthemum morifolium Ramat., Buddleja officinalis Maxim. and Sophora japonica L.
Suhui Xiong, Jingchen Xie, Feng Xiang, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119094-119094
Closed Access | Times Cited: 1
Suhui Xiong, Jingchen Xie, Feng Xiang, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119094-119094
Closed Access | Times Cited: 1
Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology
Caiyun Zhang, Hongjiao Xiang, Junmin Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116676-116676
Closed Access | Times Cited: 3
Caiyun Zhang, Hongjiao Xiang, Junmin Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116676-116676
Closed Access | Times Cited: 3
Identification of Key Drug Targets and Molecular Mechanisms of Curcumae Rhizoma Acting on HBV-Related HCC: Weighted Correlation Network and Network Pharmacological Analyses
Mengyuan Zhao, Yun Fu, Lili Liu, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 2
Mengyuan Zhao, Yun Fu, Lili Liu, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 2
Serum ESPL1 Protein as an Early Warning Biomarker for the Initial Occurrence and Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma
Bobin Hu, Deli Deng, Hengkai Liang, et al.
Research Square (Research Square) (2023)
Open Access
Bobin Hu, Deli Deng, Hengkai Liang, et al.
Research Square (Research Square) (2023)
Open Access
Screening of HRas, RRas and FOS as Potential Pharmacodynamic Candidates for the Treatment of Hepatocellular Carcinoma
Savita Mishra, Sandhya Hora, Deepshikha Pande Katare
Research Square (Research Square) (2022)
Open Access
Savita Mishra, Sandhya Hora, Deepshikha Pande Katare
Research Square (Research Square) (2022)
Open Access
Pien Tze Huang Regulates Phosphorylation of Metabolic Enzymes in Mice of Hepatocellular Carcinoma
Jin‐Xia Lin, Shicong Wang, Wenliang Lan, et al.
Research Square (Research Square) (2022)
Open Access
Jin‐Xia Lin, Shicong Wang, Wenliang Lan, et al.
Research Square (Research Square) (2022)
Open Access
